Abstract CS-03 Table 1

Pooled odds ratios for the association of hydroxychloroquine use and pregnancy outcomes

Fetal LossPreterm BirthHigh Disease ActivityPreeclampsia
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Overall 0.50 (0.27 0.94) 0.95 (0.58–1.55) 0.69 (0.35–1.39) 1.19 (0.62–2.30)
Lupus Nephritis History 0.24 (0.07 0.83) 0.81 (0.35–1.89) 0.47 (0.21–1.09) 0.70 (0.24–2.03)
No Lupus Nephritis History 0.70 (0.33–1.46) 1.04 (0.57–1.89) 0.98 (0.45–2.17) 1.36 (0.58–3.16)
APS 0.39 (0.10–1.47) 0.82 (0.23–2.96) 1.30 (0.16–10.48) 0.55 (0.12–2.45)
No APS 0.61 (0.31–1.20) 0.96 (0.56–1.64) 0.70 (0.40–1.22) 1.28 (0.58–2.84)
High Disease Activity at 1st Visit 0.61 (0.13–2.89) 1.53 (0.42–5.62) -- 0.93 (0.12–7.14)
No High Disease Activity at 1st Visit 0.46 (0.21–1.02) 0.81 (0.45–1.44) 0.73 (0.29–1.87) 1.07 (0.50–2.31)